Efficacy News and Research

RSS
FDA approves Pacira's EXPAREL for postsurgical pain management

FDA approves Pacira's EXPAREL for postsurgical pain management

HAL Allergy initiates PURETHAL Mites PHASE II study

HAL Allergy initiates PURETHAL Mites PHASE II study

Mayo Clinic, Oxford BioMedica collaborate to develop gene therapy for glaucoma

Mayo Clinic, Oxford BioMedica collaborate to develop gene therapy for glaucoma

Neutralization approach appears to prevent proliferative vitreoretinopathy

Neutralization approach appears to prevent proliferative vitreoretinopathy

Glitazone treatment does not cause side effects in patients with metastatic thyroid cancer

Glitazone treatment does not cause side effects in patients with metastatic thyroid cancer

Twelve students participate in Hartford Doctoral Fellows Program in Geriatric Social Work

Twelve students participate in Hartford Doctoral Fellows Program in Geriatric Social Work

Some experts question early release of RTS,S malaria vaccine trial data

Some experts question early release of RTS,S malaria vaccine trial data

Scientists identify nicotinamidase enzyme as new drug target for Leishmaniasis

Scientists identify nicotinamidase enzyme as new drug target for Leishmaniasis

NYUCN to study 'Midwifery: Primary Care and Health Literacy Program Enhancement'

NYUCN to study 'Midwifery: Primary Care and Health Literacy Program Enhancement'

FDA approves Medtronic's LGS IDE for clinical trial to treat Type 1 diabetes

FDA approves Medtronic's LGS IDE for clinical trial to treat Type 1 diabetes

NIH awards NYUCN $7.56M grant to study HIV risk among heterosexuals

NIH awards NYUCN $7.56M grant to study HIV risk among heterosexuals

MEDA files marketing authorization application for Dymista in Europe

MEDA files marketing authorization application for Dymista in Europe

Preventive use of ACZ may reduce risk of severe high altitude illness

Preventive use of ACZ may reduce risk of severe high altitude illness

BZL and ATLAB Pharma partner to develop 177Lu-J591 for metastatic prostate cancer treatment

BZL and ATLAB Pharma partner to develop 177Lu-J591 for metastatic prostate cancer treatment

New vaccine to eradicate meningitis

New vaccine to eradicate meningitis

Platform approach to chemically incorporate homing receptors onto surface of cells

Platform approach to chemically incorporate homing receptors onto surface of cells

Biogen Idec third quarter revenues increase 11% to $1.3 billion

Biogen Idec third quarter revenues increase 11% to $1.3 billion

American College of Gastroenterology to hold special briefing for journalists

American College of Gastroenterology to hold special briefing for journalists

Nestin-driven oncolytic viruses show effectiveness in glioblastoma models

Nestin-driven oncolytic viruses show effectiveness in glioblastoma models

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.